Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Symptom burden and functioning status in patients with advanced upper gastrointestinal cancers.
Authors
Xin Shelley Wang
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX;
Xin Shelley Wang , Lisa M. Hess , Shu-En Shen , Elizabeth Gonzalez , Mona K Jomaa , Astra M. Liepa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 311)
DOI
10.1200/JCO.2023.41.4_suppl.311
Abstract #
311
Poster Bd #
C10
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Patient-reported symptom burden and functioning in patients with advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer undergoing chemotherapy.
First Author: Xin Shelley Wang
Poster
2022 ASCO Genitourinary Cancers Symposium
Association between patient-reported outcomes (PROs) and changes in prostate-specific antigen (PSA) in patients (pts) with advanced prostate cancer treated with apalutamide (APA) in the SPARTAN and TITAN studies.
First Author: Eric Jay Small
Poster
2018 Palliative and Supportive Care in Oncology Symposium
Clinician versus patient: Who gets it right when assessing function in palliative care?
First Author: Sara Lauren Mann
Poster
2016 ASCO Annual Meeting
Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced leiomyosarcoma (LMS) or liposarcoma (LPS).
First Author: George D. Demetri